Epilepsy Treatment Shows Promise in DLB

Motor symptoms improved with add-on therapy of seizure medication. Researchers in Japan published promising data on a Phase II clinical trial on an existing medication (for seizures) in people with […]
Read More

Research Advance: DLB Genetics Uniquely Different from Parkinson’s

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]
Read More

Could a Skin Biopsy Diagnose LBD?

Could a skin biopsy diagnose LBD? New research suggests skin biopsies may hold strong potential to help diagnose dementia with Lewy bodies (DLB). The study reveals two important changes associated […]
Read More

Warning Signs of LBD Identified During Mild Cognitive Impairment Stage

To be diagnosed with Lewy body dementia (LBD), a person must first have dementia. Simply put, this means a person has had a decline in their cognitive (thinking) abilities that […]
Read More

New Diagnostic Criteria Published for DLB

If you talk with families, many will share that getting a diagnosis for one specific form of LBD, called dementia with Lewy bodies (DLB), was a challenge.  Sometimes the diagnosis […]
Read More

Biomarkers: The Pathway to Earlier LBD Diagnosis and Better Treatments

In LBD clinical research, scientists use tests that measure both the symptoms of a disease and also what biological changes are underway. Those tests that detect the presence or progression […]
Read More

Is Pure Autonomic Failure a Warning Sign of LBD?

Many people with one specific form of LBD, called dementia with Lewy bodies or DLB, develop problems with their autonomic nervous system. This is the part of the nervous system […]
Read More

Loss of Smell in Parkinson’s Disease Increases Risk of Dementia

The loss of smell is a common symptom in LBD, Parkinson’s disease and even Alzheimer’s disease. New research suggests the loss of smell in Parkinson’s disease (PD) may help predict […]
Read More

HOT NEWS: Preliminary LBD Clinical Trial Results Announced

This week Axovant Sciences released preliminary results for one of its LBD clinical trials of an experimental medication, nelotanserin. The first eleven people with LBD have completed the Phase 2 […]
Read More

LBD Duration Shortens with Co-existing Alzheimer’s Disease

The rate of progression in Lewy body dementia (LBD) is hard to predict at the time of diagnosis. New research indicates the presence of a second neurodegenerative disease process, Alzheimer’s […]
Read More